Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.0047 | 0.0068 | 0.0017 |
Leishmania major | PIF1 helicase-like protein, putative,DNA repair and recombination protein, mitochondrial precursor, putative | 0.1449 | 1 | 1 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0232 | 0.1374 | 0.133 |
Plasmodium vivax | glutathione reductase, putative | 0.0046 | 0.0061 | 0.5 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0253 | 0.1528 | 0.0679 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0175 | 0.0974 | 0.007 |
Echinococcus multilocularis | ATP dependent DNA helicase PIF1 | 0.1449 | 1 | 1 |
Schistosoma mansoni | survival motor neuron protein | 0.0047 | 0.0068 | 0.0017 |
Giardia lamblia | Rrm3p helicase | 0.1449 | 1 | 0.5 |
Brugia malayi | Thioredoxin reductase | 0.0046 | 0.0061 | 0.0403 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0253 | 0.1528 | 0.0679 |
Echinococcus granulosus | neuropeptide s receptor | 0.0453 | 0.2947 | 0.2911 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0106 | 0.0482 | 0.332 |
Loa Loa (eye worm) | hypothetical protein | 0.0232 | 0.1374 | 0.8996 |
Loa Loa (eye worm) | O-glycosyl hydrolase family 30 protein | 0.0253 | 0.1528 | 1 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0232 | 0.1374 | 0.133 |
Brugia malayi | hypothetical protein | 0.0232 | 0.1374 | 0.8996 |
Mycobacterium tuberculosis | Probable reductase | 0.0106 | 0.0482 | 0.332 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0106 | 0.0482 | 0.332 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0046 | 0.0061 | 0.0403 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0046 | 0.0061 | 0.0011 |
Loa Loa (eye worm) | hypothetical protein | 0.012 | 0.0584 | 0.3825 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0253 | 0.1528 | 0.0679 |
Trypanosoma brucei | DNA repair and recombination helicase protein PIF7 | 0.1449 | 1 | 1 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0047 | 0.0068 | 0.0443 |
Brugia malayi | glutathione reductase | 0.0046 | 0.0061 | 0.0403 |
Onchocerca volvulus | Glucosylceramidase homolog | 0.0166 | 0.091 | 1 |
Echinococcus granulosus | neuropeptide receptor A26 | 0.0453 | 0.2947 | 0.2911 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0118 | 0.0566 | 0.398 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0106 | 0.0482 | 0.332 |
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF7, putative | 0.1449 | 1 | 1 |
Echinococcus multilocularis | atpase aaa+ type core atpase aaa type core | 0.0794 | 0.5361 | 0.5338 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0106 | 0.0482 | 0.332 |
Plasmodium falciparum | thioredoxin reductase | 0.0046 | 0.0061 | 0.5 |
Entamoeba histolytica | hypothetical protein, conserved | 0.1449 | 1 | 0.5 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0253 | 0.1528 | 0.0679 |
Schistosoma mansoni | hypothetical protein | 0.1449 | 1 | 1 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0045 | 0.0051 | 0.0332 |
Leishmania major | PIF1 helicase-like protein, putative,DNA repair and recombination protein, mitochondrial precursor, putative | 0.1449 | 1 | 1 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0118 | 0.0566 | 0.398 |
Onchocerca volvulus | Huntingtin homolog | 0.012 | 0.0584 | 0.613 |
Loa Loa (eye worm) | glutathione reductase | 0.0046 | 0.0061 | 0.0403 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0046 | 0.0061 | 0.5 |
Brugia malayi | Cytochrome P450 family protein | 0.0043 | 0.0035 | 0.0227 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1449 | 1 | 1 |
Echinococcus multilocularis | neuropeptide receptor A26 | 0.0453 | 0.2947 | 0.2911 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0045 | 0.0051 | 0.0332 |
Loa Loa (eye worm) | hypothetical protein | 0.012 | 0.0584 | 0.3825 |
Toxoplasma gondii | thioredoxin reductase | 0.0046 | 0.0061 | 0.5 |
Brugia malayi | O-Glycosyl hydrolase family 30 protein | 0.0253 | 0.1528 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0175 | 0.0974 | 0.007 |
Plasmodium falciparum | glutathione reductase | 0.0046 | 0.0061 | 0.5 |
Echinococcus multilocularis | neuropeptide s receptor | 0.0453 | 0.2947 | 0.2911 |
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF6, putative | 0.1449 | 1 | 1 |
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF7, putative | 0.1449 | 1 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0253 | 0.1528 | 0.0679 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0046 | 0.0061 | 0.0011 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0225 | 0.1329 | 1 |
Entamoeba histolytica | DNA repair and recombination protein, putative | 0.1449 | 1 | 0.5 |
Trypanosoma brucei | DNA repair and recombination helicase protein PIF6 | 0.1449 | 1 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0043 | 0.0035 | 0.0227 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0118 | 0.0566 | 0.398 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0253 | 0.1528 | 0.0679 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0118 | 0.0566 | 1 |
Onchocerca volvulus | Huntingtin homolog | 0.012 | 0.0584 | 0.613 |
Brugia malayi | hypothetical protein | 0.012 | 0.0584 | 0.3825 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0106 | 0.0482 | 0.332 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.